4//SEC Filing
Gould Robert J 4
Accession 0001193125-26-004572
CIK 0001680581other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:30 PM ET
Size
5.1 KB
Accession
0001193125-26-004572
Insider Transaction Report
Form 4
Gould Robert J
Director
Transactions
- Sale
Common Stock
2026-01-02$11.87/sh−15,000$178,089→ 469,864 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.60 to $11.33, inclusive. The reporting person undertakes to provide to Fulcrum Therapeutics, Inc., any security holder of Fulcrum Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Documents
Issuer
Fulcrum Therapeutics, Inc.
CIK 0001680581
Entity typeother
Related Parties
1- filerCIK 0001577034
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:30 PM ET
- Size
- 5.1 KB